## Prevalence of Specific Phobias **Key Point:** Acrophobia (fear of heights) is the most common specific phobia in the general population, with a lifetime prevalence of approximately 5–6%. ### Epidemiology of Specific Phobias | Specific Phobia | Lifetime Prevalence (%) | Gender Ratio (F:M) | Clinical Significance | |---|---|---|---| | **Acrophobia** | 5–6 | 1.5:1 | Most common; significant functional impairment | | Arachnophobia | 3–4 | 3:1 | Common; higher in women; evolutionary preparedness | | Claustrophobia | 1–2 | 1.2:1 | Less common; often comorbid with panic disorder | | Cynophobia | 1–2 | 1:1 | Least common; often trauma-related | **High-Yield:** Acrophobia is the single most prevalent specific phobia across epidemiological studies in Western populations. It is also one of the most functionally impairing, as it restricts activities such as travel, work at heights, and leisure activities. ### Evolutionary and Neurobiological Basis Acrophobia likely reflects an evolutionarily conserved fear response to falling, which poses a genuine survival threat. The visual cliff paradigm in infants demonstrates innate sensitivity to height perception. The amygdala and insula show heightened activation in acrophobia during exposure to heights. ### Clinical Pearl Acrophobia is often ego-syntonic (the patient recognizes the fear as irrational) and responds well to cognitive-behavioral therapy (CBT) and exposure therapy. Virtual reality exposure therapy (VRET) has shown particular efficacy for acrophobia. **Mnemonic: FEAR of Heights** - **F**all risk perception - **E**volutionarily conserved - **A**mygdala-mediated - **R**esponds to exposure therapy **Warning:** Do not confuse acrophobia with vertigo or balance disorders. Acrophobia is a *phobic* disorder (anxiety-based), not a vestibular disorder.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.